Marín-Aguilera, M.; Pereira, M.V.; Jiménez, N.; Reig, Ò.; Cuartero, A.; Victoria, I.; Aversa, C.; Ferrer-Mileo, L.; Prat, A.; Mellado, B.
Glutamine and Cholesterol Plasma Levels and Clinical Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Taxanes. Cancers 2021, 13, 4960.
https://doi.org/10.3390/cancers13194960
AMA Style
Marín-Aguilera M, Pereira MV, Jiménez N, Reig Ò, Cuartero A, Victoria I, Aversa C, Ferrer-Mileo L, Prat A, Mellado B.
Glutamine and Cholesterol Plasma Levels and Clinical Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Taxanes. Cancers. 2021; 13(19):4960.
https://doi.org/10.3390/cancers13194960
Chicago/Turabian Style
Marín-Aguilera, Mercedes, María V. Pereira, Natalia Jiménez, Òscar Reig, Anna Cuartero, Iván Victoria, Caterina Aversa, Laura Ferrer-Mileo, Aleix Prat, and Begoña Mellado.
2021. "Glutamine and Cholesterol Plasma Levels and Clinical Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Taxanes" Cancers 13, no. 19: 4960.
https://doi.org/10.3390/cancers13194960
APA Style
Marín-Aguilera, M., Pereira, M. V., Jiménez, N., Reig, Ò., Cuartero, A., Victoria, I., Aversa, C., Ferrer-Mileo, L., Prat, A., & Mellado, B.
(2021). Glutamine and Cholesterol Plasma Levels and Clinical Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Taxanes. Cancers, 13(19), 4960.
https://doi.org/10.3390/cancers13194960
